From rising costs and regulatory uncertainty to persistent vaccine hesitancy, sponsors face mounting pressure to standardize operations, build community trust, and develop the behavioral capabilities needed to run vaccine trials effectively in a rapidly shifting environment.
The vaccine development landscape is under pressure from multiple directions simultaneously. Sponsors that build flexible, standardized, and community-informed trial programs will be better positioned to absorb regulatory change, accelerate timelines, and earn the public trust that ultimately determines whether vaccines reach the populations who need them.
